Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.
January 31, 2019
Mickey Schuett, president of GBMM Brokers and Consulting, talks with INSIDER editor Todd Runestad about the business of hemp. Schuett consults with many hemp-derived CBD companies. Here we discuss the following issues:
How the evangelical community is selling hemp.
How start-ups are not familiar with GMPs or even the business of taking ingredients to finished products.
Problems abiding by traceability practices and claims.
The value of lawyering up.
Whether the pharmaceutical CBD a good thing or a bad thing for CBD supplements.
You May Also Like
Tianeptine sales spur another FDA warning, action by state lawmakersFeb 20, 2024
Formulating the future: The industry may not be ready for AI in product development, and AI might not be ready for the industry, eitherFeb 20, 2024
Beyond the primary outcome: How exploratory analysis can deliver unexpected new insightsFeb 19, 2024
Survey shows dietitians concerned about TikTok misinformationFeb 16, 2024